Demorphin

Dermorphin is a naturally occurring heptapeptide first isolated from the skin secretions of South American Phyllomedusa frogs. One of its most distinctive features is the presence of a rare D-alanine residue that contributes to the peptide’s exceptional stability and biological potency.

Scientific interest in Dermorphin grew after studies demonstrated analgesic effects stronger than morphine, along with prolonged activity resulting from its resistance to enzymatic degradation.

Dermorphin may influence pain signalling through multiple mechanisms. It shows strong and selective binding to μ-opioid receptors, with its D-alanine residue thought to enhance receptor affinity. The presence of a D-amino acid also increases resistance to enzymatic breakdown. 

Some may improve penetration into the central nervous system by crossing the blood-brain barrier more efficiently through carrier-mediated transport. Additionally, studies indicate it may have a lower tendency to produce tolerance and dependence compared to morphine, while also potentially modulating descending pain pathways in the rostral ventromedial medulla involved in pain regulation.

Research applications:

• Neuropathic Pain Models 
• Analgesic Mechanism Research
• Tolerance & Dependence Studies
• Neurological Pain Circuit Research
• Receptor Pharmacology
• Comparative Opioid Investigations